• OPEN AN ACCOUNT
Indian Indices
Sensex
78,009.25 -70.71
( -0.09%)
Global Indices
Nasdaq
53,757.60 -103.39
(-0.19%)
Dow Jones
7,807.18 -12.81
(-0.16%)
Hang Seng
68,711.00 402.41
(0.59%)
Nikkei 225
10,753.31 -19.36
(-0.18%)
Forex
USD-INR
95.39 0.02
(0.02%)
EUR-INR
109.98 -0.03
(-0.03%)
GBP-INR
128.68 -0.13
(-0.10%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
539523
INE540L01014
1170.8077615
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALKEM
26.88
64553.14
EPS(TTM)
Face Value()
Div & Yield %
200.88
2
0.98
 

infosys ltd
Urja Global consolidated net profit rises 66.67% in the March 2026 quarter
May 22,2026
Net profit of Urja Global rose 66.67% to Rs 0.20 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales rose 2.33% to Rs 17.58 crore in the quarter ended March 2026 as against Rs 17.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 5.51% to Rs 1.34 crore in the year ended March 2026 as against Rs 1.27 crore during the previous year ended March 2025. Sales declined 0.82% to Rs 66.70 crore in the year ended March 2026 as against Rs 67.25 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales17.5817.18 2 66.7067.25 -1
OPM %2.674.13 -3.192.66 -
PBDT0.470.92 -49 2.482.41 3
PBT0.360.81 -56 1.992.03 -2
NP0.200.12 67 1.341.27 6